Banlasan, Ronald Jeff R.
HRN: 18-49-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFUROXIME 750MG (VIAL)
08/18/2022
08/24/2022
IVTT
750mg
Q8
PCAP C Covid Suspect
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes